Clinical Studies Sponsored by ZymoGenetics

Clinical Studies Sponsored by ZymoGenetics

Clinical Studies Sponsored by Palvella Therapeutics, Inc.

Clinical Studies Sponsored by Technical University of Madrid

Clinical Studies Sponsored by NuVasive

Cybercrime venture capital investors

List of Omnisens patents

Clinical Studies where

Trial Sponsor

is

	Name	Description	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
	‌ Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection		NCT00565539		2007	2009	Interventional
	‌ Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection		NCT01001754		2010	2012	Interventional
	‌ Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants		NCT00859547		2009	2010	Interventional
	‌ Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer		NCT00095108	Melanoma	2004	2007	Interventional
	‌ Study of Recombinant Human Thrombin for Bleeding During Surgery		NCT00245336		2005	2006	Interventional
	‌ Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma		NCT00389285		2006	2009	Interventional
	‌ Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis		NCT00491608	‌ Vascular surgery	2007	2008	Interventional
	‌ Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma		NCT00347971		2006	2008	Interventional
	‌ Immunogenicity and Safety Study of rThrombin in Surgical Hemostasis		NCT00813904		2009	2010	Interventional
	‌ Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting		NCT00371215		2006	2007	Interventional

10 results

0 selected

10 results

0 selected